Document Detail


Advances in contraception: IUDs from a managed care perspective.
MedLine Citation:
PMID:  18681819     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Contraceptive use in the United States is virtually universal among women of reproductive age. However, unplanned pregnancies continue to occur and can be largely attributed to the nonuse and misuse of contraception. Reducing unintended pregnancies constitutes a critical goal for managed care and the public. This can be achieved in part with intrauterine devices (IUDs), which are an effective method of contraception that require a one-time insertion and stay in place for 5-10 years. Therefore, compliance issues are largely mitigated, and actual use efficacy is the same as perfect use efficacy. The IUD is also reversible, unlike tubal ligation, and could potentially be the contraceptive of choice in today's environment. Unfortunately, safety concerns surrounding the use of older IUDs have precluded many women from recognizing the benefits of their use. Currently, the only approved IUDs in the United States are ParaGard, the copper IUD, and Mirena, the levonorgestrel-releasing intrauterine system (LNG-IUS). These devices offer superior safety profiles compared with those products that were withdrawn from the market in the 1970s. In addition to a favorable safety and tolerability profile, the LNG-IUS offers an advantage over copper IUDs, demonstrating improved efficacy in preventing intrauterine and ectopic pregnancies. Successful communication between patients and providers regarding the improved safety and efficacy of newer IUDs will ensure an appropriate place in therapy. Thus, greater numbers of women will recognize the IUD as a safe, cost-effective means to contraception, thereby reducing the economic and social burdens associated with unplanned pregnancies.
Authors:
John Doyle; Lee Stern; Michael Hagan; Jiayi Hao; Joseph Gricar
Related Documents :
11172799 - Ectopic gestation following emergency contraceptive pill administration.
11336429 - The levonorgestrel intrauterine system: more than a contraceptive.
11097509 - Reducing unintended pregnancy by increasing access to emergency contraceptive pills.
8489759 - Postabortal contraception.
1268519 - Letter: iud and congenital malformation.
12112969 - Release of progestin-only emergency contraception.
21419019 - Obstetric and perinatal outcome of multiple pregnancy.
8272529 - Changes in oestrogen receptor protein, mrna expression and localization in the endometr...
16524719 - Dehydroepiandrosterone and its metabolites: differential effects on androgen receptor t...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of women's health (2002)     Volume:  17     ISSN:  1931-843X     ISO Abbreviation:  J Womens Health (Larchmt)     Publication Date:    2008 Jul-Aug
Date Detail:
Created Date:  2008-08-06     Completed Date:  2008-09-25     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101159262     Medline TA:  J Womens Health (Larchmt)     Country:  United States    
Other Details:
Languages:  eng     Pagination:  987-92     Citation Subset:  IM    
Affiliation:
Analytica International, New York, New York, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Contraception / classification,  economics,  trends*
Contraceptive Agents / economics
Counseling
Family Planning Services / economics
Female
Humans
Intrauterine Devices / adverse effects,  economics,  trends*
Managed Care Programs*
Physician's Role
Pregnancy
Pregnancy, Unplanned / psychology
United States
Chemical
Reg. No./Substance:
0/Contraceptive Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The 5-item mental health index predicts the initial diagnosis of nonfatal stroke in older women.
Next Document:  Variable dosing of sertraline for premenstrual exacerbation of depression: a pilot study.